Patent ID: 11963976
Assignee: NATIONAL CHENG KUNG UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A pharmaceutical composition for treating an ischemic tissue, comprising:
a heparin or derivative thereof and a hyaluronan or derivative thereof, and optionally, one or more optional molecules selected from the group consisting of ticlopidine, warfarin, tissue plasminogen activator, anistreplase, reteplase, streptokinase, teneteplase, urokinase, prourokinase, fibrin, plasmin, a collagen, and a gelatin, the pharmaceutical composition having a viscosity greater than 10 mPa·s as measured at 20 rpm and 25° C.,
wherein the heparin or derivative thereof, the hyaluronan or derivative thereof, and the one or more optional molecules are the sole active ingredients,
wherein the hyaluronan has a mean molecular weight of 100 kDa to 5000 kDa; and
wherein the pharmaceutical composition contains the heparin or derivative thereof at 0.0001 U to 3 U per 100 μl.